TrialKidney & blood pressure research2026

Factors Influencing the Efficacy of Low-Dose Spironolactone in Adults with Chronic Kidney Disease and Type 2 Diabetes: A post hoc Analysis.

Shohei Takayama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.